Clinical trial
Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP)
NCT06628778 is registered in ClinicalTrials.gov with Johns Hopkins All Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP)
- Lead sponsor
- Johns Hopkins All Children's Hospital
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- April 15, 2027
- Completion date
- April 15, 2035
- Enrollment
- 802 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
venous thromboembolism (vte)